283 Episoden
- At CDMO Live Americas, a panel of procurement leaders shared how better RFPs, shared incentives, and two-way governance turn CDMO contracts into lasting alliances.
“We measure On-Time In-Full down to the decimal point, but we don’t even know if we trust each other.” Daniel Marasco said he once heard that line from a colleague, and it sums up a problem in many outsourcing relationships: the performance metrics are precise, but the trust behind them is weak.
Marasco was joined by Frederik Krekeler, Head of Procurement Consumer Health North America at Bayer; Susan Camden, Vice President of Business Development at Kindeva; and Lindsay Pope, Founder of Apothecary Consulting
Read the article - “We talk about external manufacturing and managing CDMOs, but 90% of your time is managing the internal team,” says Tamika Drummond.
Dr. Tamika Drummond, CEO and Founder of 3Kinnect Solutions, holds a master’s in pharmacology and a PhD in chemistry. She built her career at a prominent Canadian biotech, where she led CDMO selection, onboarding, and partnership management across biologics, monoclonal antibodies, bispecifics, and ADC programs. Before that, she worked in teaching, project management, and GMP quality assurance.
In the latest PharmaSource podcast episode, Tamika explains why CDMO selection is one of the most consequential decisions an early-stage biotech will make. She also explains why the choices that shape a program’s manufacturing future are usually made much earlier than most teams realize.
Read the full article. DC Decoded: How Section 232 Tariffs and FDA Upheaval Are Reshaping US Contract Manufacturing
09.11.2026 | 52 Min.Gil Roth, President of PBOA, and Marta Wosińska, Senior Fellow at the Brookings Institution, told CDMO Live Americas that the headline tariff rate matters far less to contract manufacturers than who actually pays it.
A 100% tariff sounds like a powerful reason to move drug manufacturing to the US. For most of the contract manufacturing market, it is not. That was a takeaway from Marta Wosińska, Senior Fellow at the Brookings Institution, in a fireside chat with Gil Roth, President of the Pharma & Biopharma Outsourcing Association (PBOA), at CDMO Live Americas 2026 in October.
Roth opened the session by discussing a Washington agenda he called 'contradictory', chasing lower drug prices and domestic manufacturing at once. Wosińska then took the audience inside the Section 232 tariffs at its center.
Download Partnerships Under Pressure, the full report from CDMO Live Americas 2026Manufacturing Network Strategy: “You Can’t Have Your Cake and Eat It”: Pfizer, Biogen, Astellas and ROIS
02.11.2026 | 35 Min.Policy shifts, tariff threats and a wave of U.S. investment announcements have left outsourcing leaders asking the same question: do you consolidate to fewer, deeper CDMO partnerships, or spread out to protect supply?
That was the debate at CDMO Live Americas in Boston, where a panel session explored manufacturing network optimization. The session, sponsored by ROIS, brought together:
Joseph Graskemper, General Manager, Early Phase Development & Manufacturing, Biogen
Gretchen Peck, Senior Director, Strategy & Program Management, Pfizer
Amber Meriwether, Corporate Strategy, Astellas
Kimberlee Steele, Chief Commercial Officer, ROIS
Read the full articleCDMO Live Americas State of the Industry: Five Takeaways on Tariffs, Reshoring, China and Talent from CDMO Live Americas 2026
27.10.2026 | 31 Min.Recorded live from CDMO Live Americas 2026.
Marta Wosińska senior fellow at The Brookings Institution, Reza Oliyai, president and CEO of Oliyai Consulting, and Kenneth Drew, vice president at Flamma, joined an interactive panel at CDMO Live Americas in Boston, reacting to live audience polling on the forces shaping contract manufacturing in 2026.
Seventy percent of the audience at the CDMO Live Americas opening panel called themselves optimistic about the next 12 months. The panel agreed on the near term, then spent half an hour on what could go wrong over the next five years. In a plenary session sponsored by Flamma, Wosińska, Oliyai and Drew responded to live audience polls on tariffs, reshoring pledges, China and the talent gap, and the room’s answers shaped the discussion at each stage. Five takeaways stood out.
Weitere Biowissenschaften Podcasts
Trending Biowissenschaften Podcasts
Über PharmaSource Podcast
Welcome to the PharmaSource podcast: the pharma and biotech podcast that explores the latest trends, challenges, and commercial opportunities shaping the biopharma manufacturing and outsourcing.
In each episode we'll be speaking with top executives, researchers, and outsourcing experts, who share their perspectives on topics such as building a smarter, more sustainable supply chain, how to partner with CDMOs, digital transformation, procurement and external manufacturing strategies, and plenty more besides.
Make sure to subscribe for your regular dose of pharma insight.
Podcast-WebsiteHöre PharmaSource Podcast, پادکست آذرخش مکری - azarakhsh mokri und viele andere Podcasts aus aller Welt mit der radio.de-App

Hol dir die kostenlose radio.de App
- Sender und Podcasts favorisieren
- Streamen via Wifi oder Bluetooth
- Unterstützt Carplay & Android Auto
- viele weitere App Funktionen



















